The report is based on the agency’s sample of nine listed hospital chains -- Apollo Hospitals, Aster DM Healthcare, Fortis Healthcare, Healthcare Global Enterprises, Krishna Institute of Medical Sciences, Max Healthcare, Narayana Hrudayalaya, Rainbow Children’s Medicare and Shalby Hospital.

Corporate hospitals to see 8-10 pc revenue growth in FY24: Report

Have no plans to dilute stake further, says BS Ajai Kumar of Healthcare Global Enterprises. Tells @prashantnair, @_soniashenoy & @Nigel_Dsouza that going forward growth will be in mid-teens at around 15-16%.


#healthcareglobal #dilutionofstakes #growthoutlook #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday   

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here. 

You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/

You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/

Subscribe to our Channel: https://bit.ly/3nvEcxf

Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News
Follow us on Instagram: https://www.instagram.com/cnbctv18india/
Catch us on: Linkedin: https://in.linkedin.com/company/cnbc-tv18
n18oc_business

HealthCare Global's BS Ajai Kumar On Plans Of Diluting Further Shares & Growth Outlook | CNBC TV18

Prabhudas Lilladher is bullish on HealthCare Global Enterprises has recommended buy rating on the stock with a target price of Rs 375 in its research report dated May 27, 2023.

Buy HealthCare Global Enterprises; target of Rs 375: Prabhudas Lilladher

Prabhudas Lilladher is bullish on HealthCare Global Enterprises has recommended buy rating on the stock with a target price of Rs 375 in its research report dated February 11, 2023.

Kaustubh Pawaskar, DVP Fundamental Research at Sharekhan by BNP Paribas highlights 5 factors why Healthcare Global Enterprises is a top buy in hospital space for 2023:

Fundamental Radar: This multibagger stock looks set to hit fresh 52-week highs in 2023; here’s why

Prabhudas Lilladher is bullish on HealthCare Global Enterprises has recommended buy rating on the stock with a target price of Rs 375 in its research report dated November 14, 2022.

ICICI Direct is bullish on Healthcare Global Enterprises recommended buy rating on the stock with a target price of Rs 370 in its research report dated November 12, 2022.

Buy Healthcare Global Enterprises; target of Rs 370: ICICI Direct

Muhurat picks: ICICIdirect recommends Axis Bank, City Union Bank, Apollo Tyres, Eicher Motors, Coforge, Lemon Tree Hotels, Healthcare Global Enterprises, Laurus Labs, Container Corp and Havells India. Check out the buying range and target price

Diwali 2022: Havells, Axis Bank, Laurus Labs, Coforge among top Muhurat Picks

Siemens Healthineers announced strategic partnerships with HealthCare Global Enterprises, Narayana Health and IISc as part of its strategy to make India an innovation centre for its global operations

Siemens Healthineers partners with HealthCare Global, Narayana Health, IISc

Prabhudas Lilladher is bullish on HealthCare Global Enterprises has recommended buy rating on the stock with a target price of Rs 358 in its research report dated August 11, 2022.

Buy HealthCare Global Enterprises; target of Rs 358: Prabhudas Lilladher

Healthcare Global Enterprises Ltd, Acrysil Ltd, Intellect Design Arena Ltd and Triveni Engineering and Industries Ltd are among the other gainers in the BSE’s ‘A’ group today, 04 March 2022.

Ujjivan Financial Services Ltd leads gainers in ‘A’ group

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Healthcare Global Enterprises Limited is a specialty healthcare provider. The Company is focused on cancer and fertility.